步长制药 (603858)

Shandong Buchang Pharmaceuticals Co., Ltd.

ASH

Tags

Special Purpose LoansTraditional Chinese MedicineCSI Share Buyback IndexGeneric DrugsInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingPharmaceuticals and HealthcareInvestments in Financial InstitutionsBelow IPO PriceHigh-Performing StocksHepatitis ConceptMargin Trading and Securities LendingHigh Price-to-Earnings Ratio

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 105456.84
  • Circulating A-Shares(W): 105456.84
  • Earnings Per Share(RMB): 0.8208
  • Net Assets Per Share(RMB): 10.0259
  • Operating Revenue(W RMB): 846858.13
  • Total Profit(W RMB): 102057.90
  • **Net Profit Attributable to Parent(W RMB) **: 86832.37
  • Net Profit Growth Rate(%): 177.54
  • Weighted Return on Equity(%): 8.2300
  • Operating Cash Flow Per Share(RMB): 0.7730
  • Undistributed Profit Per Share(RMB): 6.8318
  • Capital Reserve Per Share(RMB): 1.6423

2. Main Business

The main business covers:

  • Research, development, production and sales of Chinese patent medicines

3. Company Basic Information

  • Company Name: Shandong Buchang Pharmaceutical Co., Ltd.
  • Listing Date: 2016-11-18
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 369, Zhonghua West Road, Mudan District, Heze City, Shandong Province
  • Website: https://www.buchang.com
  • Company Profile: The company's predecessor was Shandong Buchang Pharmaceutical Co., Ltd., established on May 10, 2001 with a registered capital of 8 million yuan, later increased to 8.68552 million yuan. Based on the net assets audited by ShineWing as of September 30, 2011, Buchang Limited was converted into 612 million shares and restructured into Shandong Buchang Pharmaceutical Co., Ltd., with the balance recorded as capital reserve. ShineWing reviewed the capital contribution for this restructuring and issued the "Capital Verification Report" No. XYZH/2011CDA3028-10. This restructuring was approved by the Shandong Provincial Department of Commerce on February 17, 2012; the industrial and commercial change registration was completed on March 19, 2012, and the "Business License" with registration number 371700400000462 was obtained.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Buchang (Hong Kong) Holding Co., Ltd. General Legal Person 49095.72 46.56
2 Shoucheng International (Hong Kong) Co., Ltd. General Legal Person 8274.24 7.85
3 Tibet Danhong Enterprise Management Co., Ltd. General Legal Person 2040.84 1.94
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2038.71 1.93
5 Blue Economic Zone Industrial Investment Fund (Limited Partnership) General Legal Person 1034.28 0.98
6 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 804.20 0.76
7 Suzhou Liansheng Chemical Co., Ltd. General Legal Person 690.60 0.65
8 Invesco Great Wall CSI 300 Index Enhanced Securities Investment Fund Class A Fund 26.57 0.03
9 China Merchants Asset Management CSI 500 Index Enhanced Initiation Securities Investment Fund Class A Fund 2.16 0.00

5. Concept Sectors

  • Generic Drugs
  • Medical Aesthetics Concept
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Financial Investment
  • High P/E Ratio
  • High-Performance Stocks
  • Below IPO Price
  • Special Loans
  • CSI Buyback

Remarks

  • Data update date: 2025-11-07
  • Data source: Public Market Information